Skip to main content

Table 1 Antimicrobial resistant bacteria with cost implications in human health or in animal health and production

From: A one health framework to estimate the cost of antimicrobial resistance

  1. Important routes of transmission and the role of the environment as a reservoir of infection are indicated
  2. 1D = disease occurs due to the organism(s), C = no disease but costs associated with colonisation; H = human, A = animal, E = environment, Y = yes
  3. 2In the context of mycobacterial infection, MDR is defined as resistance to at least isoniazid and rifampin and XDR as resistance to isoniazid and rifampin and at least 3 of the 6 classes of aminoglycosides, polypeptides, fluoroquinolones, thioamides, cycloserine, and para-aminosalicyclic acid